Loading...
  • disease
  • Increasing demand for effective and potent drugs high prevalence of the disease, increasing respiratory disorders and changing lifestyles such as smoking are the high impact rendering driver for the growth of perennial allergic rhinitis market. (grandviewresearch.com)
  • include
  • Perennial Allergic rehnitis market is segmented based on the products into anti-histamines, decongestant, steroids and other treatments such as immunotherapy formulas which include desensitizing vaccines, leukotriene receptor antagonists, cromolyn formulas (sodium cromoglycate) and others. (grandviewresearch.com)
  • dosage
  • Wei H, Zhang Y, Shi L, Zhang J, Xia Y, Zang J, Yan A, Li W, Jiang X. Higher Dosage of HIFU Treatment May Lead to Higher and Longer Efficacy for Moderate to Severe Perennial Allergic Rhinitis. (medsci.org)
  • This study was to compare the efficacies and side effects of high intensity focused ultrasound (HIFU) treatment for perennial allergic rhinitis (PAR) with regular and increased dosage. (medsci.org)
  • Regular dosage of HIFU treatment was applied to 56 PAR patients in group A. An increased dosage as twice as the regular one was applied to 48 patients in group B. Nasal obstruction, sneezing, rhinorrhea and rhinocnesmus, which were recognized as the four main symptoms of allergic rhinitis (AR), were evaluated before treatment, 3 months after treatment, and 1 year after treatment. (medsci.org)
  • sprays
  • azelastine hydrochloride) clinical trial, 285 patients (115 males and 170 females) 12 years of age and older with seasonal allergic rhinitis were treated with Astepro 0.1% one or two sprays per nostril daily. (drugs.com)
  • pediatric
  • Allergic rhinitis affects the lives of over 50 million Americans as it is the third leading cause of chronic illness among children under the age of 18 years old in the U.S. Children account for 40 percent of those suffering from allergic rhinitis, resulting in 6.6 million pediatric diagnoses in 2012 alone.1 Despite abundant treatment options, there still remains an overall unmet need and dissatisfaction with medications. (fiercepharma.com)
  • dust
  • Perennial rhinitis is most often due to allergy to the house dust mite. (wiley.com)
  • To assess the benefit (and harm) of measures designed to reduce house dust mite exposure in the management of house dust mite sensitive allergic rhinitis. (wiley.com)
  • Trials to date have on the whole been small and of poor methodological quality, making it difficult to offer any definitive recommendations on the role, if any, of house dust mite avoidance measures in the management of house dust mite sensitive perennial allergic rhinitis. (wiley.com)
  • drug
  • This report provides comprehensive information on the therapeutic development for Perennial Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. (sbwire.com)
  • treatments
  • Perennial Allergic rehnitis market is segmented based on the products into anti-histamines, decongestant, steroids and other treatments such as immunotherapy formulas which include desensitizing vaccines, leukotriene receptor antagonists, cromolyn formulas (sodium cromoglycate) and others. (grandviewresearch.com)
  • Given the significant effect of thyme in reducing symptoms of allergic rhinitis and decrease IL-17 gene expression and because allergic rhinitis is a multifactorial disease, the administration of thyme extract along with conventional treatments may benefit allergic rhinitis sufferers. (rbmb.net)
  • antibody
  • criteria for allergic etiology of the disease fulfilled, i.e., positive IgE antibody test and positive eosinophil count in nasal discharge. (clinicaltrials.gov)
  • Once the allergen is inhaled through the nose, white blood cells of an allergic individual produce an antibody called immunoglobulin E (IgE). (livingnaturally.com)